H. Ho

发表

Development of an SPR-based binding assay for characterization of anti-CD20 antibodies to CD20 expressed on extracellular vesicles.

J. T. Koerber, Jihong Yang, Xiangdang Wang, 2022, Analytical biochemistry.

Isoproterenol Acts as a Biased Agonist of the Alpha-1A-Adrenoceptor that Selectively Activates the MAPK/ERK Pathway

Paul J. Dietrich, A. Ford, M. Milla, 2015, PloS one.

Facilitatory Interplay in α1a and β2 Adrenoceptor Function Reveals a Non-Gq Signaling Mode: Implications for Diversification of Intracellular Signal Transduction

A. Ford, Helen Yu, M. Milla, 2009, Molecular Pharmacology.

Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.

D. Swinney, D. Shaw, J. Barnett, 2007, Biochemistry.

The Structural Basis for Class II Cytokine Receptor Recognition by JAK1.

Y. Franke, H. Wallweber, P. Lupardus, 2016, Structure.

Discovery of a caspase cleavage motif antibody reveals insights into noncanonical inflammasome function

J. Payandeh, Yingnan Zhang, J. T. Koerber, 2021, Proceedings of the National Academy of Sciences.

Structure of the core human NADPH oxidase NOX2

D. Seshasayee, C. Arthur, J. Payandeh, 2022, Nature Communications.

Discovery of Inhibitors of the Lipopolysaccharide Transporter MsbA: From a Screening Hit to Potent Wild-Type Gram-Negative Activity.

Benjamin D. Sellers, Jun Liang, C. Koth, 2022, Journal of medicinal chemistry.

A Flexible and Scalable High-Throughput Platform for Recombinant Membrane Protein Production.

Hui Xu, C. Koth, J. Payandeh, 2019, Methods in molecular biology.

Molecular Mechanism of the Syk Activation Switch*

Emily K. Tsang, J. M. Bradshaw, A. M. Giannetti, 2008, Journal of Biological Chemistry.

Structural basis for dual-mode inhibition of the ABC transporter MsbA

Benjamin D. Sellers, Jun Liang, Y. Franke, 2018, Nature.

Therapeutic Discovery ErbB 3 Inhibitory Surrobodies Inhibit Tumor Cell Proliferation In Vitro and In Vivo

C. Hannum, R. R. Bhatt, Medini Gore, 2012 .

Activation Mechanism and Steady State Kinetics of Bruton's Tyrosine Kinase*

J. M. Bradshaw, D. Swinney, D. Shaw, 2007, Journal of Biological Chemistry.

Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist

Jun Li, Christine Tam, Daniel F. Ortwine, 2015, Science.

An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor

A. Leitner, A. Lanzavecchia, C. Arthur, 2018, Cell.

Disrupting Gram-Negative Bacterial Outer Membrane Biosynthesis through Inhibition of the Lipopolysaccharide Transporter MsbA

Benjamin D. Sellers, Cécile Chalouni, C. Koth, 2018, Antimicrobial Agents and Chemotherapy.

ErbB3 Inhibitory Surrobodies Inhibit Tumor Cell Proliferation In Vitro and In Vivo

C. Hannum, R. R. Bhatt, Medini Gore, 2012, Molecular Cancer Therapeutics.

3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models.

Alam Jahangir, Johannes C. Hermann, Seth Harris, 2013, Journal of medicinal chemistry.

Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic Analysis of Three Inhibitor Complexes

A. Kuglstatter, D. Shaw, J. Barnett, 2009, Chemical biology & drug design.

Strategies of Drug Transporter Quantitation by LC-MS: Importance of Peptide Selection and Digestion Efficiency

Yuan Chen, J. Payandeh, Liling Liu, 2017, The AAPS Journal.